Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//PSYCHOLOGY, EXPERIMENTAL | 1830502 |
130 | 3 | EPILEPSY//EPILEPSIA//EPILEPSY & BEHAVIOR | 68382 |
509 | 2 | EPILEPSY//EPILEPSY & BEHAVIOR//EPILEPSIA | 15690 |
25513 | 1 | STAVANGER NEUROL UNIT//ACRAL HYPERTROPHY//ADDUCTION LAG | 303 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | STAVANGER NEUROL UNIT | address | 156020 | 1% | 50% | 3 |
2 | ACRAL HYPERTROPHY | authKW | 104015 | 0% | 100% | 1 |
3 | ADDUCTION LAG | authKW | 104015 | 0% | 100% | 1 |
4 | AGE ACCELERATED ATHEROSCLEROSIS | authKW | 104015 | 0% | 100% | 1 |
5 | AL JAWHARAH MOL MED | address | 104015 | 0% | 100% | 1 |
6 | AREA GEST INTE A VIGO | address | 104015 | 0% | 100% | 1 |
7 | ATHEROSCLEROSIS UNIT DEV | address | 104015 | 0% | 100% | 1 |
8 | BOOALI UNIV HOSP | address | 104015 | 0% | 100% | 1 |
9 | CARBAMAZEPINE CBZ AND LEVETIRACETAM LEV | authKW | 104015 | 0% | 100% | 1 |
10 | CARBAMAZEPINE MONOTHERAPY | authKW | 104015 | 0% | 100% | 1 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Clinical Neurology | 2483 | 40% | 0% | 120 |
2 | Pharmacology & Pharmacy | 525 | 26% | 0% | 78 |
3 | Pediatrics | 194 | 10% | 0% | 29 |
4 | Neurosciences | 64 | 11% | 0% | 33 |
5 | Pathology | 62 | 5% | 0% | 14 |
6 | Medicine, General & Internal | 57 | 8% | 0% | 24 |
7 | Medical Laboratory Technology | 33 | 2% | 0% | 6 |
8 | Behavioral Sciences | 28 | 3% | 0% | 8 |
9 | Medicine, Research & Experimental | 25 | 5% | 0% | 14 |
10 | Endocrinology & Metabolism | 23 | 5% | 0% | 14 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | STAVANGER NEUROL UNIT | 156020 | 1% | 50% | 3 |
2 | AL JAWHARAH MOL MED | 104015 | 0% | 100% | 1 |
3 | AREA GEST INTE A VIGO | 104015 | 0% | 100% | 1 |
4 | ATHEROSCLEROSIS UNIT DEV | 104015 | 0% | 100% | 1 |
5 | BOOALI UNIV HOSP | 104015 | 0% | 100% | 1 |
6 | CHIEF UNIT PEDIAT NEUROL NEURODEV | 104015 | 0% | 100% | 1 |
7 | CLIN CHEM LSP1 | 104015 | 0% | 100% | 1 |
8 | CLIN SAMSUNG MED EPILEPSY PROGRAM | 104015 | 0% | 100% | 1 |
9 | CLIN SAMSUNG MED FAMILY MED | 104015 | 0% | 100% | 1 |
10 | CLIN SAMSUNG MED NEUROL | 104015 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | EPILEPSY RESEARCH | 13690 | 8% | 1% | 23 |
2 | RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY | 7671 | 4% | 1% | 13 |
3 | EPILEPSIA | 5022 | 7% | 0% | 21 |
4 | SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | 4845 | 4% | 0% | 11 |
5 | JOURNAL OF CHILD NEUROLOGY | 1331 | 3% | 0% | 8 |
6 | EPILEPSY & BEHAVIOR | 1162 | 2% | 0% | 7 |
7 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 919 | 3% | 0% | 8 |
8 | PEDIATRIC NEUROLOGY | 854 | 2% | 0% | 6 |
9 | ACTA NEUROLOGICA SCANDINAVICA | 818 | 2% | 0% | 7 |
10 | NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY | 721 | 1% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |